EdU assay indicated that cellular growth was impaired by RUNX2 knockdown, and the proliferation ability of ccRCC cells was enhanced with RUNX2 overexpression (Figures 3C and 4C). Here, RUNX2 is linked to nonpapillary renal cell carcinoma.